AstraZeneca’s best selling diabetes drug Onglyza may increase death rate: FDA
One of the best selling diabetes drug Onglyza may increase death rate as per a new FDA report which was posted on the agency's website on Friday. It comes just ahead of an April 14 meeting of an FDA advisory pa...